Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Dr. Lal Pathlabs Ltd

NSE: LALPATHLAB · BSE: 539524 · Healthcare · 17 announcements

Share price: ₹1,952.30
Market cap: ₹32,769 Cr
Revenue (annual): ₹2,763 Cr
Net profit (annual): ₹504.8 Cr
P/E (TTM): 60.5×Sector 57.8×
Promoter holding: 53.19%-0.02% QoQ
FII holding: 17.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 4 Acquisition 4 Other Announcement 3 Financial Results 3 Employee Stock Options 1 Capital Structure Change 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

25 Jul 2026 15:11 IST BSE

Financial Results

Dr. Lal Pathlabs Q1 FY27 Results: Net Profit ₹165.9 Cr, Up 28.3% YoY

Dr. Lal Pathlabs Ltd reported revenue from operations of ₹629.6 Cr (+4.7% YoY) and net profit of ₹165.9 Cr (+28.3% YoY) for Q1 FY27.

Key figure: Net profit ₹165.9 Cr · +28.3% YoY

Open full results → Read the filing ↗

24 Jul 2026 13:38 IST NSE

Financial Results

Dr. Lal Pathlabs Q1 FY27 Results: Net Profit ₹170.5 Cr, Up 27.2% YoY

Dr. Lal Pathlabs Ltd reported revenue from operations of ₹797.7 Cr (+19.1% YoY) and net profit of ₹170.5 Cr (+27.2% YoY) for Q1 FY27.

Key figure: Net profit ₹170.5 Cr · +27.2% YoY

Open full results → Read the filing ↗

30 Apr 2026 15:22 IST NSE

Financial Results

Dr. Lal Pathlabs Q4 FY26 Results: Net Profit ₹132.2 Cr, Down 15.0% YoY

Dr. Lal Pathlabs Ltd reported revenue from operations of ₹702.7 Cr (+16.6% YoY) and net profit of ₹132.2 Cr (-15.0% YoY) for Q4 FY26.

Key figure: Net profit ₹132.2 Cr · -15.0% YoY

Open full results → Read the filing ↗